Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a 13C-labeling technique

Journal of Nutrition

Volumn 142, Issue 7, 2012, Pages 1205-1212

  Maathuis, Annet J H ^a   van den Heuvel, Ellen G ^b   Schoterman, Margriet H C ^b   Venema, Koen ^a  

^a TNO   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMMONIA; BUTYRIC ACID; CARBOHYDRATE; CARBON 13; CARBOXYLIC ACID; FATTY ACID; GALACTOSE OLIGOSACCHARIDE; LACTIC ACID; PREBIOTIC AGENT; PROPIONIC ACID; RNA 16S; SYNBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; FERMENTATION; HUMAN; IN VITRO STUDY; INTESTINE FLORA; ISOTOPE LABELING; LACTOBACILLUS GASSERI; LACTOBACILLUS SALIVARIUS; LARGE INTESTINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; MICROARRAY ANALYSIS; MICROBIAL BIOMASS; NONHUMAN; PHYLOGENY; VALIDATION PROCESS;

ACETIC ACID; AMMONIA; BIFIDOBACTERIUM; CARBON ISOTOPES; COLON; FATTY ACIDS; FERMENTATION; GALACTOSE; LACTIC ACID; LACTOBACILLUS; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; OLIGOSACCHARIDES; PHYLOGENY; PREBIOTICS; PROBIOTICS; RNA, RIBOSOMAL, 16S; STAINING AND LABELING; SYNBIOTICS;

BIFIDOBACTERIUM LONGUM; LACTOBACILLUS GASSERI;

EID: 84863544278     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.157420     Document Type: Article

References (43)

1. Quigley EM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res. 2010;61:213-8.
2. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137:S830-7.
3. Tuohy KM, Rouzaud GC, Bruck WM, Gibson GR. Modulation of the human gut microflora towards improved health using prebiotics: assessment of efficacy. Curr Pharm Des. 2005;11:75-90.
4. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-19.
5. Bongers A, van den Heuvel EGHM. Prebiotics and the bioavailability of minerals and trace elements. Food Rev Int. 2003;19:397-422.
6. Weaver CM, Martin BR, Nakatsu CH, Armstrong AP, Clavijo A, McCabe LD, McCabe GP, Duignan S, Schoterman MH, van den Heuvel EG. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem. 2011;59:6501-10.
7. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104 Suppl 2:S1-63.
8. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol. 1996;216:S132-48.
9. MacFarlane S, MacFarlane GT. Proteolysis and amino acid fermentation. In: Gibson GR, MacFarlane GT, editors. Human colonic bacteria: role in nutrition, physiology and pathology. Boca Raton (FL): CRC Press; 1995. p. 75-100.
10. Rowland IR. Toxicology of the colon: role of the intestinal microflora. In: Gibson GR, Macfarlane GT, editors. Human colonic bacteria: role in nutrition, physiology, and pathology. Boca Raton (FL): CRC Press; 1995. p. 155-74.
11. Nauta A, Bakker-Zierikzee AM, Schoterman MHC. Galacto-oligosaccharides. In: Finocchiaro ET, Cho SS, editors. Handbook of prebiotics and probiotics ingredients: health benefits and food applications. Boca Raton (FL): CRC Press; 2010. p. 75-94.
12. Kovatcheva-Datchary P, Egert M, Maathuis A, Rajilic-Stojanovic M, de Graaf AA, Smidt H, de Vos WM, Venema K. Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environ Microbiol. 2009;11:914-26.
13. Minekus M. Development and validation of a dynamic model of the gastrointestinal tract [PhD thesis]. Utrecht (The Netherlands): University Utrecht; 1998.
14. Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, Alric M, Fonty G, Huis in't Veld JH. A computercontrolled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol. 1999;53:108-14.
15. van Nuenen MHMC, Meyer PD, Venema K. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis. 2003;15:137-44.
16. Venema K, van Nuenen HMC, Smeets-Peeters M, MinekusM, Havenaar R. TNO's in vitro large intestinal model: an excellent screening tool for functional food and pharmaceutical research. Ernährung. 2000;24: 558-64.
17. Maathuis A, Hoffman A, Evans A, Sanders L, Venema K. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. J Am Coll Nutr. 2009;28:657-66.
18. Rose DJ, Venema K, Keshavarzian A, Hamaker BR. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Br J Nutr. 2010;103:1514-24.
19. de Graaf AA, Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol. 2008;53:73-168.
20. Egert M, de Graaf AA, Smidt H, de Vos WM, Venema K. Beyond diversity: functional microbiomics of the human colon. Trends Microbiol. 2006;14:86-91.
21. Venema K. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J. 2012; 22:123-40.
22. Coulier L, Timmermans J, Bas R, Van Den Dool R, Haaksman I, Klarenbeek B, Slaghek T, Van Dongen W. In-depth characterization of prebiotic galacto-oligosaccharides by a combination of analytical techniques. J Agric Food Chem. 2009;57:8488-95.
23. Elia M, Cummings JH. Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur J Clin Nutr. 2007;61 Suppl 1:S40-74.
24. Gibson GR, Cummings JH, Macfarlane GT. Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol. 1988;54:2750-5.
25. Meesters RJ, van Eijk HM, ten Have GA, de Graaf AA, Venema K, van Rossum BE, Deutz NE. Application of liquid chromatography-mass spectrometry to measure the concentrations and study the synthesis of short chain fatty acids following stable isotope infusions. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;854:57-62.
26. Egert M, de Graaf AA, Maathuis A, de Waard P, Plugge CM, Smidt H, Deutz NE, Dijkema C, de Vos WM, Venema K. Identification of glucosefermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol. 2007; 60:126-35.
27. Whiteley AS, Thomson B, Lueders T, Manefield M. RNA stable-isotope probing. Nat Protoc. 2007;2:838-44.
28. Walton GE, van den Heuvel EG, Kosters MH, Rastall RA, Tuohy KM, Gibson GR. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr. 2011:1-10.
29. Davis LM, Martinez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE. 2011;6:e25200.
30. Albrecht S, Schols HA, van Zoeren D, van Lingen RA, Groot Jebbink LJ, van den Heuvel EG, Voragen AG, Gruppen H. Oligosaccharides in feces of breast- and formula-fed babies. Carbohydr Res. 2011;346: 2173-81.
31. Davis LM, Martinez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010;144:285-92.
32. Hancock V, Vejborg RM, Klemm P. Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation. Mol Genet Genomics. 2010;284:437-54.
33. Robertson D, Smith AJ. The microbiology of the acute dental abscess. J Med Microbiol. 2009;58:155-62.
34. Morrison DJ, Mackay WG, Edwards CA, Preston T, Dodson B, Weaver LT. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr. 2006;96:570-7.
35. Kandler O. Carbohydrate metabolism in lactic acid bacteria. Antonie van Leeuwenhoek. 1983;49:209-24.
36. Macfarlane GT, Cummings JH. Fermentation reactions in the large intestine. In: Roche AF, editor. Short-chain fatty acids: metabolism and clinical importance. Report of the Tenth Ross Conference on Medical Research. Columbus (OH): Ross Laboratories; 1991. p. 5-10.
37. Hambly RJ, Rumney CJ, Cunninghame M, Fletcher JM, Rijken PJ, Rowland IR. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats. Carcinogenesis. 1997;18:1535-9.
38. Clinton SK. Dietary protein and carcinogenesis. In: Rowland IR, editor. Nutrition, toxicity and cancer. Boca Raton (FL): CRC Press; 1992. p. 455-79.
39. Matsui T, Matsukawa Y, Sakai T, Nakamura K, Aoike A, Kawai K. Effect of ammonia on cell-cycle progression of human gastric cancer cells. Eur J Gastroenterol Hepatol. 1995;7 Suppl 1:S79-81.
40. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol. 1993;74:667-74.
41. Kovatcheva-Datchary P. Analyzing the functionality of the human intestinal microbiota by stable isotope probing [PhD thesis]. Wageningen (The Netherlands): University of Wageningen; 2010.
42. Bird AR, Conlon MA, Christophersen CT, Topping DL. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes. 2010;1:423-31.
43. Lee JH, O'Sullivan DJ. Genomic insights into bifidobacteria. Microbiol Mol Biol Rev. 2010;74:378-416.